S
Shufang Meng
Publications - 2
Citations - 349
Shufang Meng is an academic researcher. The author has contributed to research in topics: Adjuvant & Medicine. The author has an hindex of 2, co-authored 2 publications receiving 98 citations.
Papers
More filters
Journal ArticleDOI
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Shilong Yang,Yan Li,Lianpan Dai,Jianfeng Wang,Peng He,Changgui Li,Xin Fang,Chenfei Wang,Xiang Zhao,Enqi Huang,Changwei Wu,Zaixin Zhong,F.S. Wang,Xiaomin Duan,Siyu Tian,Lili Wu,Yan Liu,Yi Luo,Zhihai Chen,Fangjun Li,Junhua Li,Xian Yu,Hong Ren,Lihong Liu,Shufang Meng,Jinghua Yan,Zhongyu Hu,Lidong Gao,George F. Gao +28 more
TL;DR: ZF2001 as discussed by the authors is a protein subunit vaccine against COVID-19 using a dimeric form of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein as the antigen.
Posted ContentDOI
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang,Yan Li,Lianpan Dai,Jianfeng Wang,Peng He,Changgui Li,Xin Fang,Chenfei Wang,Xiang Zhao,Enqi Huang,Changwei Wu,Zaixin Zhong,F.S. Wang,Xiaomin Duan,Siyu Tian,Lili Wu,Yan Liu,Yi Luo,Zhihai Chen,Fangjun Li,Junhua Li,Xian Yu,Hong Ren,Lihong Liu,Shufang Meng,Jinghua Yan,Zhongyu Hu,Lidong Gao,George F. Gao +28 more
TL;DR: ZF2001 as mentioned in this paper is a protein subunit vaccine against COVID-19, using dimeric form of receptor-binding domain (RBD) as the antigen, and two randomized, double-blind, placebo-controlled, phase 1 and 2 trials for an RBD-based vaccine, ZF2001.